|
Talla, Venu; Yu, Hong; Chou, Tsung-Han et al. (2013) NADH-dehydrogenase type-2 suppresses irreversible visual loss and neurodegeneration in the EAE animal model of MS. Mol Ther 21:1876-88
|
|
Talla, Venu; Yang, Cui; Shaw, Gerry et al. (2013) Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis. Invest Ophthalmol Vis Sci 54:4440-50
|
|
Koilkonda, Rajeshwari D; Hauswirth, William W; Guy, John (2009) Efficient expression of self-complementary AAV in ganglion cells of the ex vivo primate retina. Mol Vis 15:2796-802
|
|
Qi, Xiaoping; Sun, Liang; Lewin, Alfred S et al. (2007) Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy. Invest Ophthalmol Vis Sci 48:5360-70
|
|
Qi, Xiaoping; Sun, Liang; Lewin, Alfred S et al. (2007) The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse. Invest Ophthalmol Vis Sci 48:1-10
|
|
Qi, Xiaoping; Hauswirth, William W; Guy, John (2007) Dual gene therapy with extracellular superoxide dismutase and catalase attenuates experimental optic neuritis. Mol Vis 13:1-11
|
|
Qi, Xiaoping; Lewin, Alfred S; Sun, Liang et al. (2007) Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci 48:681-91
|
|
Qi, Xiaoping; Lewin, Alfred S; Sun, Liang et al. (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281:31950-62
|
|
Guy, J (2000) New therapies for optic neuropathies: development in experimental models. Curr Opin Ophthalmol 11:421-9
|
|
Guy, J; Qi, X; Wang, H et al. (1999) Adenoviral gene therapy with catalase suppresses experimental optic neuritis. Arch Ophthalmol 117:1533-9
|
Showing the most recent 10 out of 22 publications
